American College of Cardiology6d
Multimodality Imaging in Cardiac Masses: Key Points
The following are key points to remember from a state-of-the-art review on multimodality imaging in the diagnostic work-up of patients with cardiac masses: ...
American College of Cardiology6d
ACC Practice Made Perfect: Precision Planning: Developing Sub-Specialty Strategies in Action
Welcome to the Cardiovascular (CV) Dyad Leadership Strategic Planning Series! In episode three of four, Ms. Amy Brownell will interview Ms. Corrin McCloskey and Dr. Joseph Goeke on developing a ...
American College of Cardiology6d
Outcomes After Transseptal MViV Replacement
This observational study reports that transseptal MViV with SAPIEN 3/SAPIEN 3 Ultra was associated with excellent procedural outcomes, low complication rates, significant improvement in valve ...
American College of Cardiology7d
2025 Medicare Physician Fee Schedule Final Rule Deep Dive
The Centers for Medicare and Medicaid Services (CMS) released the 2025 Medicare Physician Fee Schedule (PFS) final rule on Nov. 1. Of note, the 2025 PFS conversion factor is $32.3465, reduced 2.83% ...
American College of Cardiology7d
MI, HF, and Oncologic Outcomes in Breast Cancer Survivors
Breast cancer survivors who develop HF or MI face a four-fold increased risk of cancer-related death. HF shows stronger associations with adverse oncologic outcomes compared to MI alone. Findings ...
American College of Cardiology8d
Secondary MR and Percutaneous Interventions: Key Points
The following are key points to remember from a state-of-the-art review on treatment options for patients with secondary mitral regurgitation (SMR): ...
American College of Cardiology8d
Antithrombotic Therapy in High Bleeding Risk for Noncardiac Interventions: Key Points
Galli M, Gragnano F, Berteotti M, et al., on behalf of the Working Group of Thrombosis of the Italian Society of Cardiology. Citation: Antithrombotic Therapy in High Bleeding Risk Part II: Non-Cardiac ...
American College of Cardiology8d
ACCEL Lite: What Aspects of Cardiovascular Care are Most Primed for Disruption with AI?
Patients can benefit from better healthcare access and outcomes by services that are enabled by artificial intelligence (AI). The current state of technology is evolving to now allow diagnosis of ...
American College of Cardiology8d
Top Four Trials From TCT 2024: EARLY TAVR, TRISCEND II, ECLIPSE, and CLEAR SYNERGY (OASIS 9)
In this special edition of Eagle’s Eye View, Dr. Eagle looks four of the most important trials presented at the recent TCT Conference: 1) EARLY TAVR evaluating TAVR compared to clinical surveillance; ...
American College of Cardiology8d
Younger Patients Undergoing Balloon-Expandable TAVR More Likely to Have Comorbidities, Worse Outcomes at 1-Year
Patients younger than 65 years who received balloon-expandable valve TAVR for severe aortic stenosis during the low-surgical risk era were more likely to have comorbidities and exhibited higher rates ...
American College of Cardiology9d
New Blood Pressure Target For Individuals at High Risk
Elevated blood pressure is one of the strongest modifiable risk factors for the prevention of cardiovascular (CV) disease. The ESPRIT (Effects of Intensive Systolic Blood Pressure Lower Treatment in ...
American College of Cardiology9d
ACC CardiaCast: Conversations with Critical Care Cardiologists: Echo/POCUS, An Indispensable Tool in the CICU
In this episode, Drs. Rosy Thachil, Shashank Sinha, Smadar Kort and Eugene Yuriditsky discuss the critical role of echocardiography (Echo) and point-of-care ultrasound (POCUS) in the cardiac intensive ...